February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant

February 20, 2025

Medical Oddities: Sugar Sensors in the Heart?

Sugar sensors are found in the heart. Tea ingredient turned into hydrogel. Mind-reading is getting closer. And more.

Conexiant

February 20, 2025

Depressive Symptoms Surge Among U.S. High School Students

Researchers noted a "broadening of the adolescent depression risk profile."

Conexiant

February 18, 2025

Parenting Approaches Impact Teens’ Media Habits

Parental monitoring reduces teens’ exposure to mature media, while bedroom and mealtime screen access increase it, according to a study of 10,000 adolescents.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 12, 2025

FDA Approves Mirdametinib for NF1-Associated Plexiform Neurofibromas

Data from the phase III ReNeu trial showed the kinase inhibitor led to an overall response rate of 41% in adult patients and 52% in pediatric patients.

Conexiant

February 10, 2025

Bigger Mass Shooting Threat—At Home or School?

"While school shootings dominate media coverage, our work suggests that domestic violence plays a larger role in child mass shootings," write researchers.

Conexiant

February 10, 2025

Children With Autism and Medical Complexity Account for Disproportionate Health Care Costs

Children with both autism spectrum disorder and medical complexity have higher health care expenditures than those with autism spectrum disorder or medical complexity alone.

Conexiant

February 10, 2025

Guideline-Based Mental Health Treatment Gaps Identified

Researchers found significant gaps in mental health and substance use disorder treatment.

Conexiant